CYRUSONE INC. Net Change in Cash
CYRUSONE INC. reported Net Change in Cash of $74.70 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-17.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2022-02-17
- CYRUSONE INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was -$30.60M.
- CYRUSONE INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-03-31 was -$19.10M, a 130.37% decline year-over-year.
- CYRUSONE INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2019-03-31 was $62.90M, a 18.10% decline year-over-year.
- CYRUSONE INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2018-03-31 was $76.80M, a 1100.00% increase year-over-year.
- CYRUSONE INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $74.70M, a 61.73% decline from fiscal 2020.
- CYRUSONE INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $195.20M, a 1367.67% increase from fiscal 2019.
- CYRUSONE INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2019 was $13.30M.
- CYRUSONE INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2018 was -$87.50M, a 163.73% decline from fiscal 2017.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2021-12-31 | $74.70M 10-K · filed 2022-02-17 | |||
| 2021-09-30 | $207.80M 10-Q · filed 2021-10-28 | |||
| 2021-06-30 | $121.60M 10-Q · filed 2021-07-29 | |||
| 2021-03-31 | -$30.60M 10-Q · filed 2021-04-29 | |||
| 2020-12-31 | $195.20M 10-K · filed 2022-02-17 | |||
| 2020-09-30 | $80.20M 10-Q · filed 2021-10-28 | |||
| 2020-06-30 | -$5.70M 10-Q · filed 2021-07-29 | |||
| 2020-03-31 | -$19.10M 10-Q · filed 2021-04-29 | |||
| 2019-12-31 | $13.30M 10-K · filed 2022-02-17 | |||
| 2019-09-30 | -$11.40M 10-Q · filed 2020-10-29 | |||
| 2019-06-30 | $81.00M 10-Q · filed 2020-07-31 | |||
| 2019-03-31 | $62.90M 10-Q · filed 2020-04-30 | |||
| 2018-12-31 | -$87.50M 10-K · filed 2021-02-19 | |||
| 2018-09-30 | -$90.90M 10-Q · filed 2019-10-31 | |||
| 2018-06-30 | -$35.70M 10-Q · filed 2019-08-02 | |||
| 2018-03-31 | $76.80M 10-Q · filed 2019-05-02 | |||
| 2017-12-31 | $137.30M 10-K · filed 2020-02-20 | |||
| 2017-09-30 | $10.10M 10-Q · filed 2018-11-01 | |||
| 2017-06-30 | $26.20M 10-Q · filed 2018-08-02 | |||
| 2017-03-31 | $6.40M 10-Q · filed 2018-05-03 | |||
| 2016-12-31 | -$1.20M 10-K · filed 2019-02-22 | |||
| 2015-12-31 | -$20.70M 10-K · filed 2018-02-22 |